Kemp S - Search Results

1

A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs.

Hertogs K, de Béthune MP, Miller V, Ivens T, Schel P, Van Cauwenberge A, Van Den Eynde C, Van Gerwen V, Azijn H, Van Houtte M, Peeters F, Staszewski S, Conant M, Bloor S, Kemp S, Larder B, Pauwels R. Hertogs K, et al. Among authors: kemp s. Antimicrob Agents Chemother. 1998 Feb;42(2):269-76. doi: 10.1128/AAC.42.2.269. Antimicrob Agents Chemother. 1998. PMID: 9527771 Free PMC article.

2

A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance.

Larder BA, Bloor S, Kemp SD, Hertogs K, Desmet RL, Miller V, Sturmer M, Staszewski S, Ren J, Stammers DK, Stuart DI, Pauwels R. Larder BA, et al. Among authors: kemp sd. Antimicrob Agents Chemother. 1999 Aug;43(8):1961-7. doi: 10.1128/AAC.43.8.1961. Antimicrob Agents Chemother. 1999. PMID: 10428920 Free PMC article.

3

Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples.

Hertogs K, Bloor S, Kemp SD, Van den Eynde C, Alcorn TM, Pauwels R, Van Houtte M, Staszewski S, Miller V, Larder BA. Hertogs K, et al. Among authors: kemp sd. AIDS. 2000 Jun 16;14(9):1203-10. doi: 10.1097/00002030-200006160-00018. AIDS. 2000. PMID: 10894285

4

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).

Larder BA, Kemp SD. Larder BA, et al. Among authors: kemp sd. Science. 1989 Dec 1;246(4934):1155-8. doi: 10.1126/science.2479983. Science. 1989. PMID: 2479983

5

A novel polymorphism at codon 333 of human immunodeficiency virus type 1 reverse transcriptase can facilitate dual resistance to zidovudine and L-2',3'-dideoxy-3'-thiacytidine.

Kemp SD, Shi C, Bloor S, Harrigan PR, Mellors JW, Larder BA. Kemp SD, et al. J Virol. 1998 Jun;72(6):5093-8. doi: 10.1128/JVI.72.6.5093-5098.1998. J Virol. 1998. PMID: 9573280 Free PMC article.

6

Dual resistance to zidovudine and lamivudine in patients treated with zidovudine-lamivudine combination therapy: association with therapy failure.

Miller V, Phillips A, Rottmann C, Staszewski S, Pauwels R, Hertogs K, de Béthune MP, Kemp SD, Bloor S, Harrigan PR, Larder BA. Miller V, et al. Among authors: kemp sd. J Infect Dis. 1998 Jun;177(6):1521-32. doi: 10.1086/515304. J Infect Dis. 1998. PMID: 9607829

7

The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors.

Miller V, Stürmer M, Staszewski S, Gröschel B, Hertogs K, de Béthune MP, Pauwels R, Harrigan PR, Bloor S, Kemp SD, Larder BA. Miller V, et al. Among authors: kemp sd. AIDS. 1998 May 7;12(7):705-12. doi: 10.1097/00002030-199807000-00006. AIDS. 1998. PMID: 9619801

8

Structural characterization of HIV reverse transcriptase: a target for the design of specific virus inhibitors.

Tisdale M, Larder BA, Lowe DM, Stammers DK, Purifoy DJ, Ertl P, Bradley C, Kemp S, Darby GK, Powell KL. Tisdale M, et al. Among authors: kemp s. J Antimicrob Chemother. 1989 Jan;23 Suppl A:47-54. doi: 10.1093/jac/23.suppl_a.47. J Antimicrob Chemother. 1989. PMID: 2469675

9

Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting.

Harrigan PR, Hertogs K, Verbiest W, Pauwels R, Larder B, Kemp S, Bloor S, Yip B, Hogg R, Alexander C, Montaner JS. Harrigan PR, et al. Among authors: kemp s. AIDS. 1999 Oct 1;13(14):1863-71. doi: 10.1097/00002030-199910010-00008. AIDS. 1999. PMID: 10513644

10

Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy. CNA2001 Investigative Group.

Harrigan PR, Stone C, Griffin P, Nájera I, Bloor S, Kemp S, Tisdale M, Larder B. Harrigan PR, et al. Among authors: kemp s. J Infect Dis. 2000 Mar;181(3):912-20. doi: 10.1086/315317. J Infect Dis. 2000. PMID: 10720512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,117 results

Search Page

Filters